Abstract submission

For direct access to online abstract submission, click here

Call for abstracts
There will be opportunities for researchers to present their own work within the scope of the symposium, either as a proffered paper or a poster. Abstracts on cancer research pipeline within the scope of the symposium are invited. In order to be considered for presentation, abstracts need to be submitted online before or on April 30, 2008, according to the following instructions, click here. All abstracts will be reviewed by several independent experts. Notifications of acceptance or rejection, and scheduling information will be mailed to the submitting author within two weeks.

Topics for abstract submission
• Angiogenesis inhibitors
• Novel drug target
• Biomarker development and validation
• Combinations of targeted agents
• Drug design and discovery
• Drug profiles ¨C preclinical
• Drug development methodology
• Downstream signaling pathways
• Immunological targets
• Molecular diagnosis and patient selection
• Phase 1 studies
• Phase 2 studies
• Phase 3 studies
• Regulatory issues
• Target identification and validation
• Tyrosine kinase inhibitors
• Tumor vaccines
• Molecular diagnosis, patient selection and prognosis
• Survival strategies and clinical trials
• Exercise, the mind and curative intent
• Patients, research and involvement
• Symptom management
• Living with cancer as a chronic illness
• End of life care
• Cancer Epidemiology
• Frontiers and Prospects in Cancer Prevention Research
• Improving Cancer Diagnostics
• Cancer in developing countries
• The Biology and Genetics of Cells and Organisms
• The Nature of Cancer
• Tumor Viruses
• Cellular Oncogenes
• Growth Factors and their Receptors
• Cytoplasmic Signaling Circuitry Programs Many of the Traits of Cancer
• Tumor Suppressor Genes
• pRb and Control of the Cell Cycle Clock
• p53 and Apoptosis: Master Guardian and Executioner
• Eternal Life: Cell Immortalization and Tumorigenesis
• Multistep Tumorigenesis
• Maintenance of Genomic Integrity and the Development of Cancer
• Dialogue Replaces Monologue: Heterotypic Interactions and the Biology of Angiogenesis
• Moving Out: Invasion and Metastasis
• Crowd Control: Tumor Immunology and Immunotherapy
• The Rational Treatment of Cance
• Growth factor and Signalling pathways
• Structural biology
• Inflammation in cancer
• Immunological targets and mechanisms
• Methodology

Other topics
Abstract publication
All accepted abstracts will be published in the World Cancer Congress Proceedings at the meeting, and in a peer-reviewed scientific journal shortly after the meeting. Abstracts will not be released publicly prior to May 20, 2008.

Further information, should contact:
Annie Sun
Program Coordinator
E-mail: annie@bitlifesciences.com

Abstract submission for World Cancer Congress 2008

Welcome to online abstract submission for World Cancer Congress to be held in Shanghai, China, June 12-17, 2008

Fields marked with an asterisk * are mandatory fields throughout the abstract submission process.